United States · FDA National Drug Code directory
Hydralazine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68475-514_e9ca27ef-fa6d-4b88-a84b-9a56bffe2020
- Product NDC
- 68475-514
- Form
- INJECTION
- Composition / generic term
- Hydralazine Hydrochloride
- Labeler
- Navinta LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251125
- Source listing expiry
- 20271231
Source-listed ingredients
- HYDRALAZINE HYDROCHLORIDE — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL in 1 PACKAGE (68475-514-02) / 1 mL in 1 VIAL (68475-514-01) · 68475-514-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →